BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36652041)

  • 1. The role of visual electrodiagnostics in management of children with neurofibromatosis type 1.
    Tekavčič Pompe M; Pečarič Meglič N; Šuštar Habjan M
    Doc Ophthalmol; 2023 Apr; 146(2):121-136. PubMed ID: 36652041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optic Pathway Glioma and Cerebral Focal Abnormal Signal Intensity in Patients with Neurofibromatosis Type 1: Characteristics, Treatment Choices and Follow-up in 134 Affected Individuals and a Brief Review of the Literature.
    Friedrich RE; Nuding MA
    Anticancer Res; 2016 Aug; 36(8):4095-121. PubMed ID: 27466519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can screening for optic nerve gliomas in patients with neurofibromatosis type I be performed with visual-evoked potential testing?
    Wolsey DH; Larson SA; Creel D; Hoffman R
    J AAPOS; 2006 Aug; 10(4):307-11. PubMed ID: 16935228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients.
    Segal L; Darvish-Zargar M; Dilenge ME; Ortenberg J; Polomeno RC
    J AAPOS; 2010 Apr; 14(2):155-8. PubMed ID: 20451859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic factors of neurofibromatosis type 1-associated optic pathway gliomas in children].
    Florent C; Beylerian M; Mairot K; Dambricourt L; André N; David T; Girard N; Audic F; Denis D
    J Fr Ophtalmol; 2022 Feb; 45(2):173-184. PubMed ID: 34972579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic MRI in NF1 children under six years of age for the diagnosis of optic pathway gliomas. Study and outcome of a French cohort.
    Blanchard G; Lafforgue MP; Lion-François L; Kemlin I; Rodriguez D; Castelnau P; Carneiro M; Meyer P; Rivier F; Barbarot S; Chaix Y;
    Eur J Paediatr Neurol; 2016 Mar; 20(2):275-281. PubMed ID: 26774135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of pattern visual-evoked potentials to perimetry in the detection of visual loss in children with optic pathway gliomas.
    Kelly JP; Weiss AH
    J AAPOS; 2006 Aug; 10(4):298-306. PubMed ID: 16935227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visual function assessed by visually evoked potentials in optic pathway low-grade gliomas with and without neurofibromatosis type 1.
    Dotto PF; Berezovsky A; Cappellano AM; da Silva NS; Sacai PY; Silva FAB; Fernandes AG; Rocha DM; Salomão SR
    Doc Ophthalmol; 2018 Jun; 136(3):177-189. PubMed ID: 29766345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optic pathway glioma and the sex association in neurofibromatosis type 1: a single-center study.
    Henning AM; Handrup MM; Kjeldsen SM; Larsen DA; Ejerskov C
    Orphanet J Rare Dis; 2021 Nov; 16(1):489. PubMed ID: 34809690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program.
    Dalla Via P; Opocher E; Pinello ML; Calderone M; Viscardi E; Clementi M; Battistella PA; Laverda AM; Da Dalt L; Perilongo G
    Neuro Oncol; 2007 Oct; 9(4):430-7. PubMed ID: 17704361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of visual evoked potentials and optical coherence tomography in the screening for optic pathway gliomas in patients with neurofibromatosis type I.
    Vagge A; Camicione P; Pellegrini M; Gatti G; Capris P; Severino M; Di Maita M; Panarello S; Traverso CE
    Eur J Ophthalmol; 2021 Mar; 31(2):698-703. PubMed ID: 32066268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history of optic pathway gliomas in a cohort of unselected patients affected by Neurofibromatosis 1.
    Trevisson E; Cassina M; Opocher E; Vicenzi V; Lucchetta M; Parrozzani R; Miglionico G; Mardari R; Viscardi E; Midena E; Clementi M
    J Neurooncol; 2017 Sep; 134(2):279-287. PubMed ID: 28577031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term outcome of gliomas of the visual pathway in type 1 neurofibromatosis].
    Schröder S; Baumann-Schröder U; Hazim W; Haase W; Mautner VF
    Klin Monbl Augenheilkd; 1999 Dec; 215(6):349-54. PubMed ID: 10637799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visual outcomes after chemotherapy for optic pathway glioma in children with and without neurofibromatosis type 1: results of the International Society of Paediatric Oncology (SIOP) Low-Grade Glioma 2004 trial UK cohort.
    Falzon K; Drimtzias E; Picton S; Simmons I
    Br J Ophthalmol; 2018 Oct; 102(10):1367-1371. PubMed ID: 29343527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optic pathway glioma in children: does visual deficit correlate with radiology in focal exophytic lesions?
    Aquilina K; Daniels DJ; Spoudeas H; Phipps K; Gan HW; Boop FA
    Childs Nerv Syst; 2015 Nov; 31(11):2041-9. PubMed ID: 26277358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility and comparison of visual acuity testing methods in children with neurofibromatosis type 1 and/or optic pathway gliomas.
    Avery RA; Bouffet E; Packer RJ; Reginald A
    Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):1034-8. PubMed ID: 23329671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of optic pathway glioma in children with neurofibromatosis type 1 and optic nerve tortuosity or nerve sheath thickening.
    Levin MH; Armstrong GT; Broad JH; Zimmerman R; Bilaniuk LT; Feygin T; Li Y; Liu GT; Fisher MJ
    Br J Ophthalmol; 2016 Apr; 100(4):510-4. PubMed ID: 26294105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fractional anisotropy of the optic radiations is associated with visual acuity loss in optic pathway gliomas of neurofibromatosis type 1.
    de Blank PM; Berman JI; Liu GT; Roberts TP; Fisher MJ
    Neuro Oncol; 2013 Aug; 15(8):1088-95. PubMed ID: 23658320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visual outcomes and predictors in optic pathway glioma: a single centre study.
    Bowman R; Walters B; Smith V; Prise KL; Handley SE; Green K; Mankad K; O'Hare P; Dahl C; Jorgensen M; Opocher E; Hargrave D; Thompson DA
    Eye (Lond); 2023 Apr; 37(6):1178-1183. PubMed ID: 35562551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manifestations and Treatment of Adult-onset Symptomatic Optic Pathway Glioma in Neurofibromatosis Type 1.
    Mehlan J; Schüttauf F; Salamon JM; Kordes U; Friedrich RE; Mautner VF
    Anticancer Res; 2019 Feb; 39(2):827-831. PubMed ID: 30711963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.